Internal Medicine, Gastroenterology · Durham, NC
NPI
1376613109
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2100 Erwin Rd
Durham, NC, 27710
Phone (919) 620-4467
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
1,066 services
Medicare patients, 2024
219
Average age 72
Drug cost, 2024
$2.9M
619 prescriptions
Company payments, 2024
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jane Onken was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 85 times for 66 patients. In total Jane Onken billed 1,066 services in 45 codes, and Medicare paid $50K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 85 | 66 | $10.97 | $933 |
| 99215 Office E&M - Established | Office | 62 | 49 | $103.71 | $6,430 |
| 45380 Lower GI Endoscopy - Other | Facility | 50 | 50 | $86.27 | $4,314 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 35 | 28 | $10.57 | $370 |
| 45385 Colonoscopy - Lesion Removal | Facility | 32 | 32 | $180.26 | $5,768 |
| 99214 Office E&M - Established | Office | 28 | 24 | $66.23 | $1,854 |
| 91065 Test - Miscellaneous | Office | 25 | 25 | $24.48 | $612 |
| 99214 Office E&M - Established | Facility | 18 | 14 | $53.99 | $972 |
| 99215 Office E&M - Established | Facility | 16 | 15 | $93.54 | $1,497 |
| 43239 Upper GI Endoscopy | Facility | 14 | 14 | $82.51 | $1,155 |
| 99221 Hospital E&M - Initial | Facility | 13 | 13 | $51.93 | $675 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $97.22 | $1,069 |
By year: 2022 $116K for 5,638 services; 2023 $30K for 908 services; 2024 $50K for 1,066 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jane Onken prescribed most often to Medicare patients was Stelara (Ustekinumab), with 75 prescriptions and refills. In total Jane Onken wrote 619 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 75 | 110 | 13 | $2.0M |
| Famotidine Generic | 50 | 113 | 14 | $931 |
| Omeprazole Generic | 49 | 103 | 19 | $666 |
| Humira(Cf) Pen Adalimumab | 48 | 50 | Under 11 | $610K |
| Mesalamine Generic | 45 | 97 | 16 | $21K |
| Mesalamine Er Mesalamine | 32 | 78 | Under 11 | $28K |
| Esomeprazole Magnesium Generic | 29 | 75 | Under 11 | $914 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 24 | 29 | Under 11 | $1,044 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 19 | 19 | 17 | $366 |
| Prednisone Generic | 19 | 23 | 13 | $102 |
| Escitalopram Oxalate Generic | 15 | 45 | Under 11 | $256 |
| Balsalazide Disodium Generic | 15 | 32 | Under 11 | $2,005 |
| Pantoprazole Sodium Generic | 12 | 26 | Under 11 | $280 |
| Budesonide Dr Budesonide | 11 | 18 | Under 11 | $1,045 |
Brand drugs: 182 claims; generic drugs: 437 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jane Onken $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.